Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 5296 AL 5310

"Reversible" Alzheimer's disease?

Peter F, Susanne J, Margareta H, Silvia W, Wolfgang K, Thomas L, Heinz TK.

J Am Geriatr Soc. 2011 Jun;59(6):1137-8. doi: 10.1111/j.1532-5415.2011.03437.x.

Cognitive improvement with intrathecal administration of infliximab in a woman with Alzheimer's disease

Shi JQ, Wang BR, Jiang WW, Chen J, Zhu YW, Zhong LL, Zhang YD, Xu J.

J Am Geriatr Soc. 2011 Jun;59(6):1142-4. doi: 10.1111/j.1532-5415.2011.03445.x.

Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia

Ahmed MA, Darwish ES, Khedr EM, El Serogy YM, Ali AM.

J Neurol. 2012 Jan;259(1):83-92. doi: 10.1007/s00415-011-6128-4. Epub 2011 Jun 14.

Clinical amyloid imaging in Alzheimer's disease

Herholz K, Ebmeier K.

Lancet Neurol. 2011 Jul;10(7):667-70. doi: 10.1016/S1474-4422(11)70123-5.

[Semantic memory training in Alzheimer's disease]

Goudour A, Samson S, Bakchine S, Ehrlé N.

Geriatr Psychol Neuropsychiatr Vieil. 2011 Jun;9(2):237-47. doi: 10.1684/pnv.2011.0272.

Alzheimer's disease: a review of recent developments

Salawu FK, Umar JT, Olokoba AB.

Ann Afr Med. 2011 Apr-Jun;10(2):73-9. doi: 10.4103/1596-3519.82057.

Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial

Wharton W, Baker LD, Gleason CE, Dowling M, Barnet JH, Johnson S, Carlsson C, Craft S, Asthana S.

J Alzheimers Dis. 2011;26(3):495-505. doi: 10.3233/JAD-2011-110341.

A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer's disease

Stein MS, Scherer SC, Ladd KS, Harrison LC.

J Alzheimers Dis. 2011;26(3):477-84. doi: 10.3233/JAD-2011-110149.

Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics

Roberts JS, Christensen KD, Green RC.

Clin Genet. 2011 Nov;80(5):407-14. doi: 10.1111/j.1399-0004.2011.01739.x. Epub 2011 Jul 18.

Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT

Kimura N, Kumamoto T, Masuda T, Hanaoka T, Okazaki T, Arakawa R.

J Neuroimaging. 2012 Jul;22(3):299-304. doi: 10.1111/j.1552-6569.2011.00612.x. Epub 2011 Jun 23.

New developments in the search for a cure

Alkon DL.

W V Med J. 2011 May-Jun;107(3):10-3.

Region and frequency specific changes of spectral power in Alzheimer's disease and mild cognitive impairment

Roh JH, Park MH, Ko D, Park KW, Lee DH, Han C, Jo SA, Yang KS, Jung KY.

Clin Neurophysiol. 2011 Nov;122(11):2169-76. doi: 10.1016/j.clinph.2011.03.023. Epub 2011 Jun 28.

Staging Alzheimer's disease progression with multimodality neuroimaging

Ewers M, Frisoni GB, Teipel SJ, Grinberg LT, Amaro E Jr, Heinsen H, Thompson PM, Hampel H.

Prog Neurobiol. 2011 Dec;95(4):535-46. doi: 10.1016/j.pneurobio.2011.06.004. Epub 2011 Jun 22.

Parietal cortex matters in Alzheimer's disease: an overview of structural, functional and metabolic findings

Jacobs HI, Van Boxtel MP, Jolles J, Verhey FR, Uylings HB.

Neurosci Biobehav Rev. 2012 Jan;36(1):297-309. doi: 10.1016/j.neubiorev.2011.06.009. Epub 2011 Jun 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias